Cargando…

SARS‐CoV‐2 B.1.1.7 reinfection after previous COVID‐19 in two immunocompetent Italian patients

Detalles Bibliográficos
Autores principales:	Novazzi, Federica, Baj, Andreina, Genoni, Angelo, Spezia, Pietro G., Colombo, Alberto, Cassani, Gianluca, Zago, Cristian, Pasciuta, Renee, Della Gasperina, Daniela, Ageno, Walter, Severgnini, Paolo, Dentali, Francesco, Focosi, Daniele, Maggi, Fabrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242781/ https://www.ncbi.nlm.nih.gov/pubmed/33969504 http://dx.doi.org/10.1002/jmv.27066

Ejemplares similares

Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy
por: Novazzi, Federica, et al.
Publicado: (2021)

Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19
por: Focosi, Daniele, et al.
Publicado: (2021)

Detection of Torquetenovirus and Redondovirus DNA in Saliva Samples from SARS-CoV-2-Positive and -Negative Subjects
por: Spezia, Pietro Giorgio, et al.
Publicado: (2022)

A CLUSTER OF SARS‐COV‐2 DELTA VARIANT OF CONCERN ADDITIONALLY HARBORING F490S, NORTHERN LOMBARDY, ITALY
por: Novazzi, Federica, et al.
Publicado: (2022)

Spike protein evolution in the SARS-CoV-2 Delta variant of concern: a case series from Northern Lombardy
por: Baj, Andreina, et al.
Publicado: (2021)

Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy
por: Maggi, Fabrizio, et al.
Publicado: (2021)

Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy
por: Novazzi, Federica, et al.
Publicado: (2022)

Sotrovimab-emergent resistance in SARS-CoV-2 Omicron: A series of three cases
por: Focosi, Daniele, et al.
Publicado: (2022)

Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant, Lombardy, Italy
por: Baj, Andreina, et al.
Publicado: (2021)

Previous Humoral Immunity to the Endemic Seasonal Alphacoronaviruses NL63 and 229E Is Associated with Worse Clinical Outcome in COVID-19 and Suggests Original Antigenic Sin
por: Focosi, Daniele, et al.
Publicado: (2021)

Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution
por: Baj, Andreina, et al.
Publicado: (2021)

Safety and immunogenicity of synchronous COVID19 and influenza vaccination
por: Baj, Andreina, et al.
Publicado: (2022)

TTV viral load as a predictor of antibody response to SARS COV-2 vaccination
por: Focosi, Daniele, et al.
Publicado: (2023)

Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients
por: Azzi, Lorenzo, et al.
Publicado: (2021)

TTV and other anelloviruses: The astonishingly wide spread of a viral infection
por: Spezia, Pietro Giorgio, et al.
Publicado: (2023)

Genomic surveillance of SARS-CoV-2 positive passengers on flights from China to Italy, December 2022
por: Novazzi, Federica, et al.
Publicado: (2023)

SARS-CoV-2 recombinant XN, Italy
por: Novazzi, Federica, et al.
Publicado: (2022)

Plasma Torquetenovirus (TTV) microRNAs and severity of COVID-19
por: Stincarelli, Maria Alfreda, et al.
Publicado: (2022)

Is a single COVID-19 vaccine dose enough in convalescents ?
por: Focosi, Daniele, et al.
Publicado: (2021)

Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy
por: Castelli, Matteo, et al.
Publicado: (2021)

SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies
por: Focosi, Daniele, et al.
Publicado: (2021)

Lack of neutralizing activity in nonconvalescent sera, regardless of ABO blood group and anti-A isoagglutinin titer
por: Focosi, Daniele, et al.
Publicado: (2021)

Pilot Study: Long-Term Shedding of SARS-CoV-2 in Urine: A Threat for Dispersal in Wastewater
por: Baj, Andreina, et al.
Publicado: (2020)

Rise of the BQ.1.1.37 SARS-CoV-2 Sublineage, Italy
por: Focosi, Daniele, et al.
Publicado: (2023)

Pulmonary Reinfection by Nocardia in an Immunocompetent Patient with Bronchiectasis
por: Tamakoshi, Junko, et al.
Publicado: (2018)

SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?
por: Tanda, M. L., et al.
Publicado: (2022)

Mucosal immune response in BNT162b2 COVID-19 vaccine recipients
por: Azzi, Lorenzo, et al.
Publicado: (2021)

SARS-CoV-2 BA.2.86 (“Pirola”): Is it Pi or Just Another Omicron Sublineage?
por: Focosi, Daniele, et al.
Publicado: (2023)

Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine
por: Azzi, Lorenzo, et al.
Publicado: (2023)

Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study
por: Graham, Mark S, et al.
Publicado: (2021)

Saliva is a reliable tool to detect SARS-CoV-2
por: Azzi, Lorenzo, et al.
Publicado: (2020)

Immune-Mediated Mechanisms in Patients Testing Positive for SARS-CoV-2: Protocol for a Multianalysis Study
por: Ietto, Giuseppe, et al.
Publicado: (2022)

Blastomycosis of the psoas muscles
por: Ietto, Giuseppe, et al.
Publicado: (2021)

Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study
por: Abu-Raddad, Laith J., et al.
Publicado: (2021)

Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome
por: Giarretta, Igor, et al.
Publicado: (2022)

Rapid Salivary Test suitable for a mass screening program to detect SARS-CoV-2: A diagnostic accuracy study
por: Azzi, Lorenzo, et al.
Publicado: (2020)

Symptomatic Reinfection in Previously Recovered Coronavirus Disease 2019 (COVID-19) Geriatric Patient
por: Jadeja, Dhigishaba, et al.
Publicado: (2021)

Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters
por: Shiwa-Sudo, Nozomi, et al.
Publicado: (2023)

Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against reinfection with B.1.1.7 and B.1.351 variants
por: Chandrashekar, Abishek, et al.
Publicado: (2021)

Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals
por: Trinité, Benjamin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qco51cls1gtkd340lie8s9l6kq